Log In
BCIQ
Print this Print this
 

Cumulase

  Manage Alerts
Collapse Summary General Information
Company Halozyme Therapeutics Inc.
DescriptionEx vivo formulation of recombinant human PH20 hyaluronidase (rHuPH20)
Molecular Target Hyaluronan
Mechanism of ActionHormone replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationInfertility
Indication DetailsTreat oocytes to facilitate certain in vitro fertilization (IVF) procedures
Regulatory Designation
PartnerOrigio A/S

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today